89 related articles for article (PubMed ID: 7434379)
1. Plasma concentrations of misonidazole.
Notter G; Rylander U; Turesson I
Strahlentherapie; 1980; 156(10):714-8. PubMed ID: 7434379
[TBL] [Abstract][Full Text] [Related]
2. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Walker MD; Strike TA
Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
[TBL] [Abstract][Full Text] [Related]
3. The effects of misonidazole during continuous low dose rate irradiation.
Fu KK; Hurst S; Begg AC; Brown JM
Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
[TBL] [Abstract][Full Text] [Related]
4. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
Akel G; Canal P; Bugat R; Soula G; Combes PF
J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experience with daily doses of misonidazole (author's transl)].
Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
[TBL] [Abstract][Full Text] [Related]
7. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
Awwad HK; El Merzabani MM; El Badawy S; Ezzat S; Akoush H; Abd El Moneim H; Saiid A; Soliman O; Khafagy M; Burgers MV
Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and anti-tumor studies with the radiosensitizer misonidazole in dogs with spontaneous fibrosarcomas.
Creasey WA; Thrall DE
Am J Vet Res; 1982 Jun; 43(6):1015-8. PubMed ID: 7103170
[TBL] [Abstract][Full Text] [Related]
9. Misonidazole in the clinic at Mount Vernon.
Dische S
Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
[TBL] [Abstract][Full Text] [Related]
10. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
[TBL] [Abstract][Full Text] [Related]
11. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
Saunders ME; Dische S; Anderson P; Flockhart IR
Br J Cancer Suppl; 1978 Jun; 3():268-70. PubMed ID: 209808
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of misonidazole in vivo under conditions of prolonged contact of drug with the tumour cells.
Brown JM; Yu NY
Br J Radiol; 1979 Nov; 52(623):893-6. PubMed ID: 519148
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin-misonidazole: possible metabolic interaction.
Gangji D; Schwade JG; Strong JM
Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050
[TBL] [Abstract][Full Text] [Related]
14. The radioprotective effect of misonidazole (Ro-07-0582) on normal canine rectum.
Stryker JA; Albert A; Abt AB
Strahlentherapie; 1980; 156(10):719-24. PubMed ID: 7434380
[TBL] [Abstract][Full Text] [Related]
15. [Plasma levels of probucol in man after single and repeated oral doses (author's transl)].
Heeg JF; Tachizawa H
Nouv Presse Med; 1980 Oct; 9(40):2990-4. PubMed ID: 7443437
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
17. Circadian changes in the elimination of misonidazole in mouse.
Labat C; Malmary MF; Casanovas AM; Patau JP; Oustrin J
Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):331-4. PubMed ID: 6658193
[TBL] [Abstract][Full Text] [Related]
18. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
Strong JM; Schwade JG; Gangji D; Shoemaker DD; Upton DK
Cancer Clin Trials; 1981; 4(1):41-6. PubMed ID: 7214661
[No Abstract] [Full Text] [Related]
19. Plasma concentration of misonidazole and peripheral neuropathy.
Marten TR
Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
[No Abstract] [Full Text] [Related]
20. Plasma concentrations and pharmacokinetics of misonidazole after intraperitoneal administration to the mouse.
Malmary-Nebot MF; Labat C; Terrissol M; Martin B; Oustrin J
Eur J Drug Metab Pharmacokinet; 1982; 7(1):17-20. PubMed ID: 7067719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
